These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TRPV1 receptors in sensitisation of cough and pain reflexes. Adcock JJ Pulm Pharmacol Ther; 2009 Apr; 22(2):65-70. PubMed ID: 19141328 [TBL] [Abstract][Full Text] [Related]
4. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity. García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334 [TBL] [Abstract][Full Text] [Related]
5. TRPV1: a therapeutic target for novel analgesic drugs? Szallasi A; Cruz F; Geppetti P Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800 [TBL] [Abstract][Full Text] [Related]
6. TRPV1 antagonists: the challenges for therapeutic targeting. Khairatkar-Joshi N; Szallasi A Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938 [TBL] [Abstract][Full Text] [Related]
7. The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Leffler A; Mönter B; Koltzenburg M Neuroscience; 2006 May; 139(2):699-709. PubMed ID: 16515841 [TBL] [Abstract][Full Text] [Related]
8. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405 [TBL] [Abstract][Full Text] [Related]
9. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons. Katanosaka K; Banik RK; Giron R; Higashi T; Tominaga M; Mizumura K Neurosci Res; 2008 Nov; 62(3):168-75. PubMed ID: 18789982 [TBL] [Abstract][Full Text] [Related]
10. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications. Cui M; Gosu V; Basith S; Hong S; Choi S Adv Protein Chem Struct Biol; 2016; 104():81-125. PubMed ID: 27038373 [TBL] [Abstract][Full Text] [Related]
15. Modality-specific mechanisms of protein kinase C-induced hypersensitivity of TRPV1: S800 is a polymodal sensitization site. Wang S; Joseph J; Ro JY; Chung MK Pain; 2015 May; 156(5):931-941. PubMed ID: 25734989 [TBL] [Abstract][Full Text] [Related]
16. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse. Sándor K; Helyes Z; Elekes K; Szolcsányi J Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661 [TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential vanilloid 1 as a therapeutic target in analgesia. Szolcsányi J; Pintér E Expert Opin Ther Targets; 2013 Jun; 17(6):641-57. PubMed ID: 23421411 [TBL] [Abstract][Full Text] [Related]
18. Physiological and behavioral evidence of a capsaicin-sensitive TRPV-like channel in the medicinal leech. Summers T; Holec S; Burrell BD J Exp Biol; 2014 Dec; 217(Pt 23):4167-73. PubMed ID: 25324339 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Wong GY; Gavva NR Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372 [TBL] [Abstract][Full Text] [Related]
20. [The TRPV1 channel as a target for the treatment of pain]. Salazar H; Jara-Oseguera A; Rosenbaum T Rev Neurol; 2009 Apr 1-15; 48(7):357-64. PubMed ID: 19319817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]